Bullish option flow detected in Teva with 5,874 calls trading, 1.1x expected, and implied vol increasing almost 4 points to 49.69%. Dec-24 19 calls and Dec-24 17 calls are the most active options, with total volume in those strikes near 4,300 contracts. The Put/Call Ratio is 0.11. Earnings are expected on November 6th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEVA:
- Teva biosimilar candidate is accepted for review by U.S. FDA, E.U. EMA
- Teva call volume above normal and directionally bullish
- Teva, mAbxience expand partnership to include additional biosimilar candidate
- Teva put volume heavy and directionally bearish
- Teva launches generic version of Sandostatin LAR Depot in the U.S.